Dipropylamine as base for the use in fmoc deprotection in solid-phase peptide synthesis
US-2026042795-A1 · Feb 12, 2026 · US
using activating agents {(C07K1/003, C07K1/006 take precedence)}
using activating agents {(C07K1/003, C07K1/006 take precedence)} · Cooperative Patent Classification (CPC)
Chemical and metallurgical processes, compounds, and materials.
Related technology areas
Mapped technology topics for this CPC code.
| Metric | Value |
|---|---|
| CPC code | C07K1/08 |
| Official title | using activating agents {(C07K1/003, C07K1/006 take precedence)} |
| Display label | using activating agents {(C07K1/003, C07K1/006 take precedence)} |
| Total patents | 51 |
Filing trend
Year-over-year patent counts classified under this CPC code.
Filing activity over the last five years is declining.
| Year | Patents |
|---|---|
| 2015 | 2 |
| 2016 | 6 |
| 2017 | 3 |
| 2018 | 7 |
| 2019 | 6 |
| 2020 | 1 |
| 2021 | 8 |
| 2022 | 6 |
| 2023 | 2 |
| 2024 | 5 |
| 2025 | 4 |
| 2026 | 1 |
Representative patents
Representative publications under this CPC code from precomputed stats, or recent filings when stats are unavailable.
Protein modifying reagent
US-2025361264-A1 · Nov 27, 2025 · US
Production method for peptide compound
US-2025276995-A1 · Sep 4, 2025 · US
Liquid phase peptide synthesis methods
US-2025188118-A1 · Jun 12, 2025 · US
Method for producing peptide compound
US-12240871-B2 · Mar 4, 2025 · US
Readily isolated bispecific antibodies with native immunoglobulin format
US-12157758-B2 · Dec 3, 2024 · US
Solid phase peptide synthesis processes and associated systems
US-2024383944-A1 · Nov 21, 2024 · US
Method and apparatus for producing peptide
US-2024368215-A1 · Nov 7, 2024 · US
Solid phase peptide synthesis processes and associated systems
US-2024368216-A1 · Nov 7, 2024 · US
Solid phase peptide synthesis processes and associated systems
US-11878996-B2 · Jan 23, 2024 · US
New synthetic methods using native chemical ligation in flow
US-2023133885-A1 · May 4, 2023 · US
Peptoid compound and manufacturing method thereof, oligomer, pharmaceutical composition, and kit
US-11591370-B2 · Feb 28, 2023 · US
Readily Isolated Bispecific Antibodies with Native Immunoglobulin Format
US-2022389055-A1 · Dec 8, 2022 · US
Solid phase peptide synthesis processes and associated systems
US-2022275021-A1 · Sep 1, 2022 · US
Method for producing peptide compound
US-2022153777-A1 · May 19, 2022 · US
Method for producing amide
US-2022144884-A1 · May 12, 2022 · US
Conformationally-preorganized, MiniPEG-containing gamma-peptide nucleic acids
US-11279736-B2 · Mar 22, 2022 · US
Readily Isolated Bispecific Antibodies with Native Immunoglobulin Format
US-2022024973-A1 · Jan 27, 2022 · US
Readily isolated bispecific antibodies with native immunoglobulin format
US-11168111-B2 · Nov 9, 2021 · US
CONFORMATIONALLY-PREORGANIZED, MiniPEG-CONTAINING GAMMA-PEPTIDE NUCLEIC ACIDS
US-2021214397-A1 · Jul 15, 2021 · US
Frequently asked questions
Answers are generated from the same data shown on this page.
- What is CPC C07K1/08?
- CPC C07K1/08 is the Cooperative Patent Classification code for “using activating agents {(C07K1/003, C07K1/006 take precedence)}.”
- How many patents are filed under CPC C07K1/08 (using activating agents {(C07K1/003, C07K1/006 take precedence)})?
- Our database includes 51 publications tagged with this CPC code.
- Is patent activity under CPC C07K1/08 growing?
- Publication counts under this code: 5 in 2024 vs 4 in 2025 (latest complete years).